ArticleDrug design, development and therapy2016

Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: results from a first-in-human single ascending dose study.

Hongrong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.